Flavodoxin-Like Proteins Protect Candida albicans from Oxidative Stress and Promote Virulence.
The fungal pathogen Candida albicans causes lethal systemic infections in humans. To better define how pathogens resist oxidative attack by the immune system, we examined a family of four Flavodoxin-Like Proteins (FLPs) in C. albicans. In agreement with previous studies showing that FLPs in bacteria and plants act as NAD(P)H quinone oxidoreductases, a C. albicans quadruple mutant lacking all four FLPs (pst1Δ, pst2Δ, pst3Δ, ycp4Δ) was more sensitive to benzoquinone. Interestingly, the quadruple mutant was also more sensitive to a variety of oxidants. Quinone reductase activity confers important antioxidant effects because resistance to oxidation was restored in the quadruple mutant by expressing either Escherichia coli wrbA or mammalian NQO1, two distinct types of quinone reductases. FLPs were detected at the plasma membrane in C. albicans, and the quadruple mutant was more sensitive to linolenic acid, a polyunsaturated fatty acid that can auto-oxidize and promote lipid peroxidation. These observations suggested that FLPs reduce ubiquinone (coenzyme Q), enabling it to serve as an antioxidant in the membrane. In support of this, a C. albicans coq3Δ mutant that fails to synthesize ubiquinone was also highly sensitive to oxidative stress. FLPs are critical for survival in the host, as the quadruple mutant was avirulent in a mouse model of systemic candidiasis under conditions where infection with wild type C. albicans was lethal. The quadruple mutant cells initially grew well in kidneys, the major site of C. albicans growth in mice, but then declined after the influx of neutrophils and by day 4 post-infection 33% of the mice cleared the infection. Thus, FLPs and ubiquinone are important new antioxidant mechanisms that are critical for fungal virulence. The potential of FLPs as novel targets for antifungal therapy is further underscored by their absence in mammalian cells.
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
Lifang
L
Li
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
Shamoon
S
Naseem
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
Sahil
S
Sharma
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
James B
JB
Konopka
D000818:Animals; D002176:Candida albicans / Q000254:growth & development / Q000276:immunology / Q000378:metabolism* / Q000472:pathogenicity; D002177:Candidiasis / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D002478:Cells, Cultured; D005260:Female; D005418:Flavodoxin / Q000737:chemistry / Q000378:metabolism; D005420:Flavoproteins / Q000235:genetics / Q000378:metabolism*; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism*; D017353:Gene Deletion; D057131:Immune Evasion; D007527:Isoenzymes; D008264:Macrophages / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D008807:Mice, Inbred BALB C; D050296:Microbial Viability; D009247:NADH, NADPH Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D013379:Substrate Specificity; D014451:Ubiquinone / Q000737:chemistry / Q000378:metabolism; D014774:Virulence
D005418:Flavodoxin; D005420:Flavoproteins; D005656:Fungal Proteins; D007527:Isoenzymes; D014451:Ubiquinone; D009247:NADH, NADPH Oxidoreductases